[Antiphospholipid antibodies and systemic scleroderma. Apropos of a case with review of the literature].
Marrakchi
H
H
Service de dermatologie, Hôpital Charles Nicolle, Tunis.
Fazaa
B
B
Gorgi
Y
Y
Jellouli
A
A
Mokhtar
I
I
Kamoun
M R
MR
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D017152:Antibodies, Antiphospholipid / Q000032:analysis*; D016736:Antiphospholipid Syndrome / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D001168:Arthritis / Q000473:pathology; D003078:Colchicine / Q000627:therapeutic use; D005260:Female; D006074:Gout Suppressants / Q000627:therapeutic use; D006801:Humans; D007213:Indomethacin / Q000627:therapeutic use; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000473:pathology; D011928:Raynaud Disease / Q000473:pathology; D012595:Scleroderma, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D017152:Antibodies, Antiphospholipid; D006074:Gout Suppressants; D003078:Colchicine; D007213:Indomethacin
Anticorps antiphospholipides et sclérodermie systémique. A propos d'un cas avec revue de la littérature.